Meanwhile, Zou et al. [38] reported that insulin pretreatment significantly augments the anticancer functions of 5-FU in colonic (Ls-174-t) and human esophageal (Eca 109) cancer cells, leading to increased apoptosis, altered cell cycle distribution, and enhanced inhibition of cell proliferation. The gene discussed is INS; the disease is cancer.